申请人:Array BioPharma Inc.
公开号:US20130072500A1
公开(公告)日:2013-03-21
The present invention provides compounds of Formula I including tautomers, resolved enantiomers, resolved diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.
Also provided are methods of using the compounds of this invention as Akt protein kinase inhibitors and for the treatment of Akt-mediated diseases, for example, hyperproliferative diseases such as cancer.
本发明提供了公式I的化合物,包括互变异构体、已分离的对映体、已分离的非对映异构体、溶剂化物、代谢物、盐以及其药学上可接受的前药。此外,本发明还提供了使用这些化合物作为Akt蛋白激酶抑制剂以及用于治疗Akt介导的疾病,例如,癌症等增殖性疾病的方法。